Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Ning Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1410-329X; OpenAlex author ID A5100387207. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. DSG2 promotes pancreatic cancer stem cell maintenance via support of tumour and macrophage cellular cross-talk. Co-author DOI 10.1038/s41419-025-07833-4↗
  2. WITHDRAWN: Exogenous HMGB1 promotes pancreatic cancer progression by supporting the crosstalk between tumor and myeloid-derived suppressor cell Last author DOI 10.21203/rs.3.rs-3886646/v1↗
  3. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Co-author DOI 10.1016/j.apsb.2023.01.020↗
  4. iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy First author DOI 10.21203/rs.3.rs-2470450/v1↗
  5. The therapeutic potential of natural products for treating pancreatic cancer. First author DOI 10.3389/fphar.2022.1051952↗
  6. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression. Co-author DOI 10.1002/ctm2.467↗
  7. microRNA and gene networks in human pancreatic cancer. Co-author DOI 10.3892/ol.2013.1521↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Faming Wang · 2 shared papers, 2024–2025 · strength 0.58
  2. Yibin Feng · 2 shared papers, 2021–2023 · strength 0.34
  3. Chien‐shan Cheng · 2 shared papers, 2021–2023 · strength 0.34
  4. Qiang Yan · 1 shared paper, 2025 · strength 0.30
  5. Wei Wei · 1 shared paper, 2024 · strength 0.28
  6. Liqin Li · 1 shared paper, 2024 · strength 0.28
  7. Yi Wang · 1 shared paper, 2022 · strength 0.20
  8. Xia He · 1 shared paper, 2022 · strength 0.20
  9. Yau-Tuen Chan · 1 shared paper, 2023 · strength 0.19
  10. Ting Deng · 1 shared paper, 2023 · strength 0.18
  11. Rui Liu · 1 shared paper, 2023 · strength 0.18
  12. Zhi Ji · 1 shared paper, 2023 · strength 0.18
  13. Duo Zuo · 1 shared paper, 2023 · strength 0.18
  14. Tiansuo Zhao · 1 shared paper, 2023 · strength 0.18
  15. Yi Ba · 1 shared paper, 2023 · strength 0.18
  16. Zhen Chen · 1 shared paper, 2021 · strength 0.15
  17. Zhiqiang Meng · 1 shared paper, 2021 · strength 0.15
  18. Lianyu Chen · 1 shared paper, 2021 · strength 0.15
  19. Yang Li · 1 shared paper, 2013 · strength 0.05
  20. Minghui Zhu · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.